Thailand AMH Low IVF Hospital Selection Guide: When AMH Below What Level Requires Hospital Evaluation

AI Summary

Clinical Diagnostic Criteria for Low AMH

AMH (Anti-Müllerian Hormone) is secreted by granulosa cells of ovarian preantral and small antral follicles and is one of the most stable indicators for assessing ovarian reserve. Low AMH is clinically defined as below 1.0 ng/mL, and below 0.5 ng/mL indicates severe depletion. However, it should be noted that normal reference ranges vary between different assay platforms (Roche, Beckman, Antu, etc.), and AMH still fluctuates by 5–10% during the menstrual cycle. Therefore, a single result needs to be interpreted in conjunction with other indicators.

Key Interpretation Low AMH itself does not directly determine pregnancy outcome, but it directly affects expected egg yield. Clinical decision-making should also simultaneously reference FSH, LH, E2, and antral follicle count. The accuracy of combined assessment using all four indicators is far higher than using a single indicator.

Analysis of Causes for Low AMH

The causes of low AMH are multifactorial. Identifying the etiology helps formulate targeted treatment strategies. The following are common clinical causes:

• Age Factor: Ovarian reserve naturally declines after age 35, with accelerated decline after age 40.
• Premature Ovarian Insufficiency (POI): Ovarian function declines before age 40, with an incidence of about 1%.
• Iatrogenic Factors: Ovarian cystectomy, salpingectomy, chemotherapy, pelvic radiotherapy, etc.
• Autoimmune Factors: Autoimmune diseases such as Hashimoto's thyroiditis, Addison's disease can affect the ovaries.
• Genetic Factors: FMR1 gene premutation, Turner syndrome mosaicism, etc.
• Idiopathic: Unknown cause, accounting for about 30–40%.

For individuals planning to undergo IVF in Thailand, it is recommended to complete etiological screening before departure. If it is an autoimmune or genetic factor, it may affect protocol selection or even necessitate egg donation; if it is an age factor, the focus should be on optimizing the ovarian stimulation protocol rather than reversing ovarian function.

Doctor's Perspective on Evaluating Low AMH

When reproductive doctors evaluate low AMH, they focus not only on the numerical value but on the following four dimensions:

• Rate of Decline: The rate of AMH decline over 6–12 months has more prognostic value than a single value. Rapid decline suggests accelerated ovarian function depletion.
• Consistency with Antral Follicle Count: If AMH is low but antral follicle count is acceptable, be wary of assay error or platform differences; if both are low, diminished reserve is confirmed.
• Prediction of Ovarian Stimulation Response: Patients with low AMH have a higher response threshold to FSH, requiring higher starting doses or switching to more potent stimulation protocols.
• Potential Impact on Embryo Quality: Whether low AMH is accompanied by decreased egg quality varies individually. Generally, age is the main factor affecting egg quality, while AMH primarily affects egg quantity.

During the initial consultation at a Thai IVF hospital, doctors will use the above dimensions to determine whether an autologous egg cycle is suitable and to choose between mild stimulation, natural cycle, PPOS, or luteal phase stimulation protocols.

Differences in Low AMH Across Age Groups

The clinical significance of low AMH varies significantly with age, and management strategies should differ accordingly.

Patients under 35 with low AMH, despite low egg yield, usually have good embryo quality, with cumulative pregnancy rates reaching 40–50%. However, patients over 40 have a higher rate of embryonic chromosomal abnormalities (60–70%), and the live birth rate per single transfer is significantly lower, requiring more attention to embryo selection and cumulative cycle planning.

Evaluation Dimensions for Thai IVF Hospitals

For patients with low AMH, when choosing a Thai IVF hospital, the following four technical dimensions should be prioritized, rather than just looking at success rate numbers or prices.

Laboratory Conditions

• Embryo Culture Technology: Whether equipped with Time‑lapse incubators and AI embryo assessment systems. These technologies are particularly important for embryo selection in low-yield cycles.
• Laboratory Accreditation: International certifications like CAP, ISO 15189 reflect the laboratory's quality management level.
• Follicular Fluid Recovery Technique: In cases with extremely low egg yield, efficient follicular fluid recovery techniques can reduce egg loss.

Doctor Experience

• Annual Number of Mild Stimulation / Natural Cycle Cases: The number of low AMH patients a doctor handles personally each year directly impacts protocol proficiency.
• Strategies for Low Response: Proficiency in advanced techniques like PPOS, luteal phase stimulation, dual trigger, etc.
• Specialized Treatment Unit: Some large hospitals have dedicated advanced age / low AMH clinics, implying a more systematic diagnostic and treatment process.

Protocol Design Capability

• Individualized Stimulation Protocol: Customizing protocols based on AMH, FSH, antral follicle count, BMI, rather than a standardized process.
• Trigger Timing Selection: Experience with GnRH‑a trigger vs hCG trigger. In low-yield cases, trigger timing directly affects egg maturity.
• Luteal Phase Support Protocol: Special luteal support for low-yield patients, such as increased progesterone dose or combined GnRH‑a use.

Interpreting Success Rate Data

• Stratified Statistics by Age and AMH: Avoid being misled by overall success rates; request data for the AMH<1.0 group.
• Cumulative Pregnancy Rate: Single transfer success rate has limited reference value for low AMH patients; cumulative pregnancy rate better reflects true performance.
• Embryo Freeze-Thaw Survival Rate: The maturity of the laboratory's vitrification technology directly affects the feasibility of cumulative cycles.

Easily Overlooked Testing Details

In the evaluation of low AMH, the following details are often overlooked but can directly impact clinical decisions:

• Assay Platform Differences: Normal ranges vary between platforms like Roche, Beckman, Antu. A new baseline must be established when changing platforms.
• Accuracy of Antral Follicle Count: Depends on the sonographer's experience. It is recommended to repeat the scan at the same hospital, on the same machine, and by the same operator.
• Time Lag Between FSH and AMH: FSH elevation usually lags behind AMH decline by 6–12 months, so normal FSH does not rule out diminished reserve.
• Vitamin D Level: Vitamin D deficiency is positively correlated with AMH levels; supplementation can partially improve AMH values.
• Thyroid Function: Individuals positive for thyroid autoantibodies have an increased risk of low AMH and require simultaneous evaluation.

These details are easily missed during initial consultations at Thai IVF hospitals but can influence treatment plan selection and even cycle decisions. It is recommended to complete basic tests domestically before departure and bring all reports for consultation.

Common Misconceptions When Choosing a Hospital

Based on clinical observations, patients with low AMH are prone to the following cognitive biases when selecting a Thai IVF hospital:

• Misconception 1: Focusing solely on single-cycle success rate. The single transfer success rate for low AMH patients is naturally lower than the normal population; focus on cumulative pregnancy rate rather than single-cycle data.
• Misconception 2: Believing low AMH only allows mild stimulation. Some patients with AMH 0.5–1.0 and acceptable antral follicle count may achieve better egg yield with a gentle stimulation protocol.
• Misconception 3: Ignoring age-related differences in laboratory requirements. Embryos from different age groups have different requirements for culture environment; embryos from low AMH patients need more stable culture conditions.
• Misconception 4: Overemphasizing price differences. The impact of technical capability on low AMH patients far outweighs price differences; low prices may indicate insufficient laboratory investment.
• Misconception 5: Assuming low AMH equals poor egg quality. AMH reflects quantity, not quality. Young patients with low AMH typically have normal egg quality.

Interpretation of Test Indicators: AMH and Related Markers

Interpreting low AMH requires combined analysis with the following indicators to obtain a complete picture of ovarian function:

The better the consistency between AMH and AFC, the more reliable the assessment. If they are inconsistent (e.g., low AMH but normal AFC), it is recommended to repeat the tests after 2–3 months to rule out assay error.